HücreCELL® Biotechnology was established with the "Induced Pluripotent Stem Cell (iPSC)-based Diabetes Disease Model" R&D project #2200299, which was carried out and successfully completed between 01.11.2020 and 30.04.2022 within the scope of TÜBİTAK 1512 - Individual Young Entrepreneur (BIGG) Technoenterprise Capital Support Programme, and continues to be supported by R&D project #7238013 titled "Investigation of Tissue Damage at the microRNA (miRNA) and Exosomal miRNA Levels in iPSC-based Diabetes Disease Models and Determination of Potential Biomarkers", to be carried out between 01.07.2023 and 30.11.2024 within the scope of TÜBİTAK 1507 - SME R&D Initial Support Program.